Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Scheinberg

Showing results (81-90 of 172) with videos related to

Pageof 18
Sort By:
Cancer Research|November 4, 2010
Selective killing of tumor neovasculature paradoxically improves chemotherapy delivery to tumorsFreddy E Escorcia, Erik Henke, Michael R McDevitt, et al.
International Journal of Nanomedicine|November 3, 2010
Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubesAlessandro Ruggiero, Carlos H Villa, Jason P Holland, et al.
Oncoimmunology|June 9, 2021
Low-dose CDK4/6 inhibitors induce presentation of pathway specific MHC ligands as potential targets for cancer immunotherapyAngel Charles, Christopher M Bourne, Tanya Korontsvit, et al.
Blood|June 26, 2004
Targeted deletion of T-cell clones using alpha-emitting suicide MHC tetramersRui Rong Yuan, Phillip Wong, Michael R McDevitt, et al.
Leukemia Research|March 10, 2005
Immune therapy of chronic myelogenous leukemiaRobert Peter Gale, Mary M Horowitz, Moshe Talpaz, et al.
Assay and Drug Development Technologies|December 24, 2011
A high-throughput scintillation proximity-based assay for human DNA ligase IVHui-Min Tseng, David Shum, Bhavneet Bhinder, et al.
Oncoimmunology|March 5, 2016
T cell receptor mimic antibodies for cancer therapyLeonid Dubrovsky, Tao Dao, Ron S Gejman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
CD8+ T-cell-dependent immunity following xenogeneic DNA immunization against CD20 in a tumor challenge model of B-cell lymphomaMaria Lia Palomba, Wendy K Roberts, Tao Dao, et al.
JCI Insight|September 8, 2020
Solving an MHC allele-specific bias in the reported immunopeptidomeMartin G Klatt, Kyeara N Mack, Yang Bai, et al.
Expert Opinion on Biological Therapy|April 21, 2016
Opportunities and challenges for TCR mimic antibodies in cancer therapyAaron Y Chang, Ron S Gejman, Elliott J Brea, et al.
Pageof 18

Showing results (81-90 of 172) with videos related to

Sort By:
Pageof 18
Cancer Research|November 4, 2010
Selective killing of tumor neovasculature paradoxically improves chemotherapy delivery to tumorsFreddy E Escorcia, Erik Henke, Michael R McDevitt, et al.
International Journal of Nanomedicine|November 3, 2010
Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubesAlessandro Ruggiero, Carlos H Villa, Jason P Holland, et al.
Oncoimmunology|June 9, 2021
Low-dose CDK4/6 inhibitors induce presentation of pathway specific MHC ligands as potential targets for cancer immunotherapyAngel Charles, Christopher M Bourne, Tanya Korontsvit, et al.
Blood|June 26, 2004
Targeted deletion of T-cell clones using alpha-emitting suicide MHC tetramersRui Rong Yuan, Phillip Wong, Michael R McDevitt, et al.
Leukemia Research|March 10, 2005
Immune therapy of chronic myelogenous leukemiaRobert Peter Gale, Mary M Horowitz, Moshe Talpaz, et al.
Assay and Drug Development Technologies|December 24, 2011
A high-throughput scintillation proximity-based assay for human DNA ligase IVHui-Min Tseng, David Shum, Bhavneet Bhinder, et al.
Oncoimmunology|March 5, 2016
T cell receptor mimic antibodies for cancer therapyLeonid Dubrovsky, Tao Dao, Ron S Gejman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
CD8+ T-cell-dependent immunity following xenogeneic DNA immunization against CD20 in a tumor challenge model of B-cell lymphomaMaria Lia Palomba, Wendy K Roberts, Tao Dao, et al.
JCI Insight|September 8, 2020
Solving an MHC allele-specific bias in the reported immunopeptidomeMartin G Klatt, Kyeara N Mack, Yang Bai, et al.
Expert Opinion on Biological Therapy|April 21, 2016
Opportunities and challenges for TCR mimic antibodies in cancer therapyAaron Y Chang, Ron S Gejman, Elliott J Brea, et al.
Pageof 18